STEFFANIE MCCOMBS: Open Payments
NPI 1841960507 · BRUNSWICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 36 payments from 12 companies in 2025. Trend: 2023 $768 · 2024 $734 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $203 |
| PFIZER INC. | 6 | $112 |
| Novo Nordisk Inc | 5 | $107 |
| Amgen Inc. | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $40 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $29 |
| Esperion Therapeutics, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: OTEZLA, BREZTRI, AIRSUPRA, PREVNAR 20, Wegovy, Rybelsus, JARDIANCE, FARXIGA.
Industry payments across MD — which companies pay providers there.
